Full Press Release Details
CGuard Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January
2020, in Leipzig, Germany
Clinical Presentations, Updates, and Panel Discussions on CGuard EPS to also be presented
Aviv, Israel- January 27, 2020 - InspireMD, Inc. (NYSE American: NSPR), a leader in embolic prevention systems (EPS)
/ thrombus management technologies and neurovascular devices, today announced that its CGuard Carotid Embolic Prevention
System (EPS) will be featured in a live case transmission at the Leipzig Interventional Course (LINC) 2020 to be held from January
28th to the 31st at the Trade Fair Leipzig, Hall 2 in Leipzig, Germany. CGuard EPS will also be featured in three panel
discussions and two scientific posters at the conference.
10:18 - 10:48 Live from Bergamo Technical Forum Room 3
17 - BG 03: male, 82 years (P-R)
high-risk coronary artery disease
F. Castriota, A. Micari
presentations featuring CGuard EPS will include:
Immediate and one-month results from a prospective real-world multicentre clinical practice of CAS using the CGuard embolic prevention
system: The IRONGUARD 2 study P. Sirignano
January 28, 12:45 - 12:50 PM Central European Time
Room 6 - Speaker's Corner
Accumulating long-term evidence for the MicroNet-covered stent safety, efficacy and durability in primary and secondary stroke
prevention: 5-year data from the PARADIGM-Extend prospective academic trial P. Musialek
January 28, 12:50 - 12:55 PM Central European Time
Room 6 - Speaker's Corner
OPTIMAI endovascular sequestration of high-risk carotid plaque using the CGuard MicroNET-covered embolic prevention stent
system in consecutive patients with symptoms or signs of carotid stenosis-related brain injury: An intravascular ultrasound -
controlled investigator-initiated multicentric multi-specialty study (CGuard OPTIMA) P. Musialek
January 28, 12:55 - 13:00 PM Central European Time
Room 6 - Speaker's Corner
Reconstruction of left subclavian artery using carotid technology B. Huasen
January 28, 14:30 - 14:35 PM Central European Time
The use of CGuard stents; U.K. experience B. Huasen
January 28, 16:35 - 16:40 PM Central European Time
CGuard Carotid Embolic Prevention System will also be featured at the Company's booth (16d2). InspireMD will be represented
by its management, sales and clinical staff and welcomes all enquiries from clinicians and other interested parties.
is a leading global forum for new methods in the field of vascular medicine. LINC brings together medical professionals from different
specialties around the world who perform endovascular interventions.
seeks to utilize its proprietary MicroNet technology to make its products the industry standard for embolic protection
and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization,
no reflow and major adverse cardiac events.
intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard ), neurovascular, and peripheral
artery procedures. InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants
are quoted on the NYSE American under the ticker symbol NSPR.WS.